The Role of CXCL12 and CXCR4 in Kidney Cancer Spread
Author Information
Author(s): Pan Judong, Mestas Javier, Burdick Marie D, Phillips Roderick J, Thomas George V, Reckamp Karen, Belperio John A, Strieter Robert M
Primary Institution: David Geffen School of Medicine at UCLA
Hypothesis
The biological axis of CXCL12 via interaction with its receptor, CXCR4, is a major mechanism for renal cell carcinoma (RCC) metastasis.
Conclusion
The CXCL12/CXCR4 biological axis plays a critical role in regulating organ-specific metastasis of renal cell carcinoma.
Supporting Evidence
- CXCR4 was significantly expressed on circulating cytokeratin+ RCC cells from patients with known metastatic RCC.
- Neutralization of CXCL12 in SCID mice abrogated metastasis of RCC to target organs expressing high levels of CXCL12.
- The expression of CXCR4 on human RCC directly correlated with their metastatic ability in vivo.
Takeaway
This study found that a specific protein called CXCR4 helps kidney cancer cells spread to other parts of the body, and blocking its partner, CXCL12, can stop this spread.
Methodology
The study involved measuring CXCR4 expression on circulating cytokeratin+ cells in patients with metastatic RCC and using mouse models to assess the role of CXCL12/CXCR4 in metastasis.
Potential Biases
Potential bias in patient selection and the use of animal models may not fully represent human disease.
Limitations
The study primarily focused on a specific biological axis and did not explore other potential pathways involved in RCC metastasis.
Participant Demographics
21 patients with metastatic renal cell carcinoma and 3 normal control subjects.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website